L-Asparaginase: Toxicity to Normal and Leukemic Human Lymphocytes-Reference-Cited by-同舟云学术

L-Asparaginase: Toxicity to Normal and Leukemic Human Lymphocytes

Published:1967-01-20 Issue:3760 Volume:155 Page:329-330
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Schrek Robert¹,Dolowy William C.²,Ammeraal Robert N.²

Affiliation:

1. Tumor Research Laboratory, Veterans Administration Hospital, Hines, Illinois

2. Medical Research Laboratory, University of Illinois, Chicago

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference26 articles.

1. UNPUBLISHED DATA

2. BOYSE, E.A., INHIBITORY EFFECT OF GUINEA PIG SERUM ON A NUMBER OF NEW LEUKAEMIAS IN MICE, NATURE 198: 800 (1963).

3. BROOME, J.D., EVIDENCE THAT L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS .2. LYMPHOMA 6C3HED CELLS CULTURED IN A MEDIUM DEVOID OF L-ASPARAGINE LOSE THEIR SUSCEPTIBILITY TO EFFECTS OF GUINEA PIG SERUM IN VIVO, JOURNAL OF EXPERIMENTAL MEDICINE 118: 121 (1963).

4. BROOME, J.D., ANTILYMPHOMA ACTIVITY OF L-ASPARAGINASE IN VIVO - CLEARANCE RATES OF ENZYME PREPARATIONS FROM GUINEA PIG SERUM AND YEAST IN RELATION TO THEIR EFFECT ON TUMOR GROWTH, JOURNAL OF THE NATIONAL CANCER INSTITUTE 35: 967 (1965).

5. BROOME, J.D., EVIDENCE THAT L-ASPARAGINASE ACTIVITY OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS, NATURE 191: 1114 (1961).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignancies;2023-03-15

2. Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities;Cancers;2022-05-24

3. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL;Blood Advances;2022-01-10

4. Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance;Pharmaceutics;2021-11-19

5. Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma;Surgical Oncology Clinics of North America;2021-10